Sep 09, 2021 / 04:40PM GMT
Lawrence H. Biegelsen - Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
All right. Good afternoon for those of you on the East Coast, and good morning for those of you on the West Coast. I'm Larry Biegelsen, the medical device analyst. And it's my pleasure to host this session with the management team -- or the CEO, I should say, of Penumbra, Adam Elsesser. In terms of format, it's going to be a fireside chat. (Operator Instructions) We're going to try with the polling questions, which have been going pretty well.
And I think that's it. Adam, thanks for joining us.
Adam Elsesser - Penumbra, Inc. - Co-Founder, Chairman, President & CEO
Yes. Thanks for having us.
Questions and Answers:
Lawrence H. Biegelsen - Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research AnalystAll right. So why don't we jump in start with the COVID question, unfortunately? Next year, hopefully, we won't be asking about COVID. But just I'd love